Newsletter Archive

31. 03.26.24 -- Notable Public Comments On The FDA's Proposed Regulation For Laboratory Developed Tests 3/26/2024
    03/26/24 Laboratory Network Newsletter
32. 03.12.24 -- FDA's CBER Issues Final Guidance For CAR T Cell Products 3/12/2024
    03/12/24 Laboratory Network Newsletter
33. 02.27.24 -- FDA Issues Final Guidance: Reformulating Drug Products That Contain Carbomers Manufactured With Benzene 2/27/2024
    02/27/24 Laboratory Network Newsletter
34. 02.13.24 -- FDA Issues Draft Guidance For Cell & Gene Therapy Potency Assurance 2/13/2024
    02/13/24 Laboratory Network Newsletter